Suchergebnisse - "Yoshimura, Akihiro"

PubPharm (103)

1

Japanese sake making using wild yeasts isolated from natural environments

enthalten in: Bioscience, biotechnology, and biochemistry | 2024

von Nakagawa, T. | Yoshimura, A. | Sawai, Y. | +3

2

Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy

enthalten in: International cancer conference journal | 2024

von Yoshimura, A. | Yamamoto, Y. | Nishikawa, T. | +9

3

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49% : a multicenter retrospective study

enthalten in: Frontiers in oncology | 2024

von Yoshimura, A. | Takeda, T. | Kataoka, N. | +18

4

Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer

enthalten in: ResearchSquare.com | 2023

von Horinaka, M. | Yoshimura, A. | Yaoi, T. | +5

5

First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression : A Real-World Multicenter Retrospective Study

enthalten in: Cancers | 2023

von Tanimura, K. | Takeda, T. | Kataoka, N. | +18

6

Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy

enthalten in: International Cancer Conference journal | 2023

von Yoshimura, A. | Yamamoto, Y. | Nishikawa, T. | +9

7

Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib : A case report

enthalten in: Respirology case reports | 2023

von Takei, S. | Yoshimura, A. | Yamamoto, C. | +8

8

Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy : A Multicenter Retrospective Study

enthalten in: Cancers | 2023

von Tanimura, K. | Takeda, T. | Yoshimura, A. | +11

9

Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Morimoto, K. | Yamada, T. | Sawada, R. | +15

10

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy

enthalten in: Drugs & aging | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]